Microneedle Flu Vaccine Market size was valued at USD 121.5 Million in 2024 and is forecasted to grow at a CAGR of 16.5% from 2026 to 2033, reaching USD 450 Million by 2033.
The South Korean microneedle flu vaccine market is experiencing significant growth, driven by technological advancements and increasing demand for efficient vaccination methods. Microneedle technology offers a minimally invasive and painless alternative to traditional injections, enhancing patient compliance and streamlining vaccine administration.
Microneedles, typically less than a millimeter in length, deliver vaccines directly into the skin's immune-rich layers, potentially eliciting stronger immune responses. This method reduces the risk of needle-stick injuries and allows for self-administration, making it particularly appealing in both developed and developing regions. The global microneedle flu vaccine market was valued at USD 1.6 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2032.
In South Korea, SK Bioscience has been at the forefront of vaccine innovation. The company resumed production of its cell-based flu vaccine, SKYCellflu, in 2023 after a two-year hiatus to focus on COVID-19 vaccines. By early 2024, approximately five million doses of SKYCellflu were supplied domestically, with the vaccine also receiving approval in 10 countries, including Malaysia, Thailand, and Singapore. Unlike traditional egg-based vaccines, SKYCellflu is produced using cell culture methods, making it suitable for individuals with egg allergies and reducing the risk of mutations during production.
The adoption of microneedle technology in flu vaccinations aligns with the South Korean pharmaceutical industry's emphasis on innovation and patient-centric solutions. The market's expansion is further supported by the increasing prevalence of influenza and the need for more effective vaccination methods. Additionally, the convenience of self-administration and reduced dependency on healthcare professionals make microneedle vaccines particularly attractive in various healthcare settings.
As the microneedle flu vaccine market continues to evolve, ongoing research and development efforts are expected to introduce more advanced and effective products. The focus on enhancing vaccine delivery methods and improving patient experiences positions South Korea as a key player in the global microneedle flu vaccine market.
Get an In-Depth Research Analysis of the South Korea Microneedle Flu Vaccine Market Size And Forecast [2025-2032]
Sanofi
GC Pharma
Debiotech
NanoPass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Microneedle Flu Vaccine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Microneedle Flu Vaccine Market
Solid Microneedles
Hollow Microneedles
Dissolving Microneedles
Coated Microneedles
Preventive Vaccine
Therapeutic Vaccine
Research and Development
Healthcare Facilities
Research Laboratories
Homecare Settings
Intradermal Delivery
Subcutaneous Delivery
Intramuscular Delivery
Approved Microneedle Vaccines
Clinical Trial Microneedle Vaccines
Investigational Microneedle Products
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Microneedle Flu Vaccine Market Research Analysis
1. Introduction of the South Korea Microneedle Flu Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Microneedle Flu Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Microneedle Flu Vaccine Market, By Type
6. South Korea Microneedle Flu Vaccine Market, By Application
7. South Korea Microneedle Flu Vaccine Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Microneedle Flu Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/